Outflow Tract VT (RVOT, LVOT & Aortic Cusp VT)

Outflow tract ventricular tachycardia (OT-VT) is the most common form of idiopathic VT, accounting for approximately 60–80% of all idiopathic ventricular arrhythmias. It encompasses a spectrum of arrhythmias arising from the right ventricular outflow tract (RVOT), left ventricular outflow tract (LVOT), aortic root cusps, aortomitral continuity, and the epicardial ventricular summit. OT-VT typically occurs in patients with structurally normal hearts and carries a benign prognosis, although high PVC burden (>10–15%) can lead to tachycardia-mediated cardiomyopathy if left untreated.

The dominant mechanism is triggered activity mediated by cyclic AMP (cAMP)–dependent delayed afterdepolarizations (DADs). Sympathetic stimulation increases intracellular cAMP via beta-adrenergic receptor activation and adenylyl cyclase, which in turn activates protein kinase A (PKA). PKA phosphorylates the ryanodine receptor (RyR2) and phospholamban, leading to calcium overload in the sarcoplasmic reticulum. Spontaneous calcium release from the overloaded SR activates the sodium-calcium exchanger (NCX), generating a transient inward current (I_ti) that produces DADs. When DADs reach threshold, they trigger action potentials and sustain the arrhythmia.

The RVOT is the most common site of origin, accounting for approximately 70–80% of all outflow tract VTs. Within the RVOT, the septal aspect is more common than the free wall. The LVOT accounts for the remaining 20–30% and includes origins from the left coronary cusp (LCC), right coronary cusp (RCC), the LCC-RCC junction (interleaflet triangle), the aortomitral continuity (AMC), and the epicardial ventricular summit region accessible via the great cardiac vein (GCV) and anterior interventricular vein (AIV).

Epicardial origins deserve special attention. The ventricular summit is the most epicardial aspect of the LV, bounded by the left anterior descending artery (LAD), the left circumflex artery (LCx), and the GCV. Arrhythmias arising from the summit may be inaccessible to endocardial ablation due to the overlying coronary vasculature and epicardial fat, and may require ablation from within the GCV/AIV, the aortic cusps, or occasionally a surgical/percutaneous epicardial approach.

The 12-lead ECG during outflow tract VT or PVCs is the single most important tool for localizing the site of origin prior to the EP study. All outflow tract arrhythmias share a common feature: an inferior axis with tall R waves in leads II, III, and aVF, reflecting the superior-to-inferior activation vector from the base of the heart toward the apex. The key differentiating features are the bundle branch morphology, precordial transition, R-wave amplitude in V1–V2, QRS duration, and lead I morphology.

RVOT Localization

RVOT VT produces a left bundle branch block (LBBB) morphology with inferior axis. The precordial R-wave transition is typically late (V3–V4 or later) because the activation begins in the anterior RV and moves leftward and posteriorly. Within the RVOT, septal origins produce a narrower QRS (<140 ms), earlier precordial transition, and a more positive R-wave in lead I, while free wall origins produce a wider QRS (>140 ms), later transition, and notching on the QRS downstroke in the inferior leads.

LVOT and Cusp Localization

LVOT origins produce earlier precordial transition (V1–V3) compared to RVOT, because the activation begins further leftward and posterior. Aortic cusp VTs have distinctive features: tall R waves in V1–V2 (RBBB-like or early transition pattern), reflecting leftward and posterior origin relative to the precordial leads. The LCC produces the tallest R waves in V1–V2 due to its posterior and leftward position. The RCC produces relatively smaller R waves in V1–V2 but still with earlier transition than RVOT. The LCC-RCC junction shows intermediate features. An M-shaped or W-shaped pattern in V1 is a clue to cusp origin.

ECG Algorithms for Localization

Several validated algorithms aid in distinguishing RVOT from LVOT/cusp origins. The transitional zone index compares the R-wave transition during VT/PVC to that during sinus rhythm — if the VT transition is earlier than sinus (transitional zone index ≤0), an LVOT or cusp origin is likely. An R-wave duration index (R-wave duration / QRS duration in V1 or V2) ≥0.50 and an R/S amplitude ratio ≥0.30 in V1 or V2 suggest an LVOT or cusp origin rather than RVOT. A negative or isoelectric lead I favors a leftward (LVOT/LCC) origin, while a positive lead I favors RVOT.

The EP study for outflow tract VT focuses on inducing the clinical arrhythmia, precisely localizing the site of origin using activation and pace mapping, and guiding catheter ablation. Because OT-VT is catecholamine-dependent triggered activity, induction often requires isoproterenol infusion (typically 2–20 mcg/min) combined with burst pacing or programmed stimulation from the RV.

Induction Strategies

OT-VT may present as frequent PVCs, repetitive monomorphic VT (RMVT), or sustained VT. Isoproterenol is the cornerstone of induction — it increases intracellular cAMP and facilitates DAD-mediated triggered activity. Burst pacing from the RV apex or RVOT at cycle lengths of 300–500 ms with isoproterenol is the most effective induction protocol. Unlike reentrant VT, OT-VT typically cannot be induced by programmed stimulation with premature extrastimuli alone (the hallmark of triggered activity). A period of rapid pacing ("warm-up") may be needed to load the SR with calcium before the arrhythmia sustains.

Activation Mapping

During VT or PVCs, activation mapping identifies the site of earliest ventricular activation relative to the QRS onset. The target is the site where the local electrogram precedes the surface QRS by 20–40 ms (or more). This represents the focal origin of the triggered activity. Electroanatomic mapping systems (CARTO, EnSite) create three-dimensional activation maps that display the centrifugal spread of activation from the earliest site. A tight, focal activation pattern (all surrounding electrograms later) confirms a point source of origin consistent with triggered activity.

Pace Mapping

Pace mapping is a complementary technique used when the arrhythmia is infrequent or non-sustained. Pacing at the site of origin should reproduce the clinical PVC/VT morphology with 12/12 lead concordance on the surface ECG. A perfect (12/12) pace map match, combined with short stimulus-to-QRS time (<40 ms), indicates that the pacing site is at or very near the origin. Pace mapping is especially valuable for localizing cusp origins, where the earliest activation may be recorded at multiple nearby sites due to far-field signals.

Distinguishing OT-VT from Arrhythmogenic Cardiomyopathy

An important role of the EP study is to distinguish benign idiopathic OT-VT from arrhythmogenic right ventricular cardiomyopathy (ARVC), which also arises from the RV outflow region. Key differences include: ARVC often shows fractionated, low-voltage electrograms and late potentials in the RVOT/RV, multiple VT morphologies, abnormal RV voltage maps, and inducibility with programmed stimulation (reentrant mechanism). If any of these features are present, further evaluation with cardiac MRI and genetic testing is warranted before proceeding with ablation.

Catheter ablation is highly effective for outflow tract VT, with success rates exceeding 90% for RVOT origins and 80–85% for LVOT/cusp origins. Ablation is indicated for symptomatic patients, those with high PVC burden causing cardiomyopathy, or patients who fail or do not tolerate medical therapy (beta-blockers, calcium channel blockers).

RVOT Ablation

RVOT ablation is technically straightforward. The ablation catheter is advanced to the RVOT via femoral venous access. Using a combination of activation mapping and pace mapping, the earliest activation site is identified. Radiofrequency (RF) energy is applied with standard 4 mm or irrigated-tip catheters. Power settings of 25–35 W are typically sufficient for the thin-walled RVOT. Acute success rates exceed 90–95% for septal RVOT origins, with recurrence rates of 5–10%. Free wall origins have slightly lower success due to catheter instability and wall thinness (risk of perforation), and may benefit from irrigated-tip catheters with contact force sensing.

Aortic Cusp Ablation

Cusp ablation requires retrograde aortic access and mapping within the aortic root. The catheter is positioned within the aortic sinuses (LCC, RCC, or LCC-RCC junction) under ICE and fluoroscopic guidance. Coronary angiography is mandatory before energy delivery to confirm a safe distance (≥5–10 mm) from the coronary ostia. RF energy is applied at 20–30 W with irrigated-tip catheters to limit thrombus formation in the arterial system. The LCC is the most common cusp origin (~75% of cusp VTs), followed by the RCC and the LCC-RCC junction. Success rates for cusp ablation are 80–90%, with slightly higher recurrence compared to RVOT ablation.

Summit and Epicardial VT

The ventricular summit represents the most challenging subset of OT-VT for ablation. Due to the overlying coronary vasculature and epicardial fat pad, direct epicardial ablation is often precluded. A stepwise approach is recommended: (1) attempt ablation from the nearest endocardial site (LCC, AMC, or LVOT), (2) attempt ablation from within the GCV or AIV using small-caliber ablation catheters, and (3) consider percutaneous epicardial access or surgical cryoablation for truly inaccessible sites. Coronary angiography is mandatory before any epicardial or GCV/AIV ablation to delineate the relationship to the LAD and LCx arteries.

Complications

Complications vary by ablation site. RVOT ablation carries a small risk of pericardial effusion/tamponade (especially free wall ablation), pulmonary valve injury, and RVOT perforation. Cusp ablation risks include coronary artery injury (if ablation is too close to the ostia), aortic valve damage (leaflet perforation or new aortic regurgitation), stroke (thromboembolic events in the arterial system), and coronary spasm. GCV/AIV ablation carries risks of coronary venous perforation, damage to adjacent coronary arteries, and limited energy delivery due to the small vessel diameter. The overall major complication rate is low (<2–3%) in experienced centers.